Nephropathy in type 2 diabetes: Current therapeutic strategies
RE Gilbert, DJ Kelly
Nephrology | Published : 2001
Diabetic nephropathy is currently the commonest cause of end-stage renal failure in most countries with a Western lifestyle. In addition to progressing to end-stage renal disease, patients with type 2 diabetes and nephropathy are at especially high risk of cardiovascular death. A multifaceted approach, aiming not only to slow the progression of renal dysfunction but also to reduce the risk of associated complications, particularly cardiovascular disease, is advocated. Current evidence-based guidelines serve a useful adjunctive role in providing target levels for therapeutic intervention.